COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,223 Articles (22,733 medRxiv, 8,490 bioRxiv)

Most recent first Previous |  Page 2851: Articles 28501-28510  | Next

Structure of anxiety associated with the COVID-19 pandemic in the Russian-speaking sample: results from on-line survey
Sorokin, M. Y., Kasyanov, E. D., Rukavishnikov, G. V., Makarevich, O. V., Neznanov, N. G., Lutova, N. B., Mazo, G. E.
10.1101/2020.04.28.20074302 — Posted: 2020-05-04
Development and validation of direct RT-LAMP for SARS-CoV-2
Mohon, A. N., Hundt, J., van Marle, G., Pabbaraju, K., Berenger, B., Griener, T., Lisboa, L., Church, D., Czub, M., Greninger, A., Jerome, K., Doolan, C., Pillai, D. R.
10.1101/2020.04.29.20075747 — Posted: 2020-05-04
A cohort of patients with COVID-19 in a major teaching hospital in Europe
Borobia, A. M., Carcas, A. J., Arnalich, F., Alvarez-Sala, R., Montserrat, J., Quintana, M., Figueira, J. C., Torres Santos-Olmo, R. M., Garcia-Rodriguez, J., Martin-Vega, A., Ramirez, E., Buno, A., Martinez-Ales, G., Garcia-Arenzana, N., Marti de Gracia, M., Moreno, F., Reinoso-Barbero, F., Martin-Quiros, A., Rivera, A., Mingorance, J., Carpio, C. C., Prieto Arribas, D., Rey Cuevas, E., Prados, M. C., Rios, J. J., Hernan, M., Frias, J., Arribas, J. R., COVID@HULP working team
10.1101/2020.04.29.20080853 — Posted: 2020-05-04 Discussion: Onsite
A national prospective cohort study of SARS/COV2 pandemic outcomes in the U.S.: The CHASING COVID Cohort
Robertson, M., Kulkarni, S., Berry, A., Mirzayi, C., Maroko, A. R., Zimba, R., Westmoreland, D., Grov, C., Parcesepe, A., Waldron, L., Nash, D.
10.1101/2020.04.28.20080630 — Posted: 2020-05-04 Discussion: Onsite
Full-spectrum dynamics of the coronavirus disease outbreak in Wuhan, China: a modeling study of 32,583 laboratory-confirmed cases
Hao, X., Cheng, S., Wu, D., Wu, T., Lin, X., Wang, C.
10.1101/2020.04.27.20078436 — Posted: 2020-05-04
Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19
Huang, M., Li, M., Xiao, F., Liang, J., Pang, P., Tang, T., Liu, S., Chen, B., Shu, J., You, Y., Li, Y., Tang, M., Zhou, J., Jiang, G., Xiang, J., Hong, W., He, S., Wang, Z., Feng, J., Lin, C., Ye, Y., Wu, Z., Li, Y., Zhong, B., Sun, R., Hong, Z., Liu, J., Chen, H., Wang, X., Li, Z., Pei, D., Tian, L., Xia, J., Jiang, S., Zhong, N., Shan, H.
10.1101/2020.04.26.20081059 — Posted: 2020-05-04 Discussion: Onsite
Enzyme immunoassay for SARS-CoV-2 antibodies in dried blood spot samples: A minimally-invasive approach to facilitate community- and population-based screening
McDade, T. W., McNally, E., D'Aquila, R. T., Mustanski, B., Miller, A., Vaught, L., Reiser, N., Bogdanovic, E., Zelikovich, A., Demonbreun, A.
10.1101/2020.04.28.20081844 — Posted: 2020-05-04
COVID-19 Pandemic Response Simulation: Impact of Non-pharmaceutical Interventions on Ending Lockdowns
Lee, S., Zabinsky, Z. B., Kofsky, S. M., Liu, S.
10.1101/2020.04.28.20080838 — Posted: 2020-05-04
Analysis of hospitalized COVID-19 patients in the Mount Sinai Health System using electronic medical records (EMR) reveals important prognostic factors for improved clinical outcomes
Wang, Z., Zheutlin, A. B., Kao, Y.-H., Ayers, K. L., Gross, S. J., Kovatch, P., Nirenberg, S., Charney, A. W., Nadkarni, G. N., O'Reilly, P. F., Just, A. C., Horowitz, C. R., Martin, G., Branch, A. D., Glicksberg, B. S., Charney, D. S., Reich, D. L., Oh, W. K., Schadt, E. E., Chen, R., Li, L.
10.1101/2020.04.28.20075788 — Posted: 2020-05-04 Discussion: Onsite
Population vulnerability to COVID-19 in Europe: a burden of disease analysis
Wyper, G. M., Assuncao, R. M., Cuschieri, S., Devleeschauwer, B., Fletcher, E., Haagsma, J. A., Hilderink, H., Idavain, J., Lesnik, T., Von der Lippe, E., Majdan, M., Milicevic, M. S., Pallari, E., Penalvo, J. L., Pires, S. M., Plass, D., Santos, J. V., Thomsen, S. T., Stockton, D. L., Grant, I.
10.1101/2020.04.29.20064279 — Posted: 2020-05-04 Discussion: Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).